Female Viagra May Get FDA’s Approval
The US FDA advisory panel will consider whether to approve a drug that will increase the sexual libido of women with hypoactive sexual desire disorder (HSDD). The drug called flibanserin was developed by Boehringer Ingelheim.
Flibanserin, first developed as an antidepressant works by reducing serotonin levels in the brain thereby reducing signals from areas of the brain that inhibit feeling desire.
According to Boehringer Ingelheim: "women deserve options and we're hoping flibanserin may represent a safe and effective option for many women."
Flibanserin (dubbed as pink Viagra) increases the sexual libido in women as does Viagra in men. Trials conducted by the manufacturer resulted in an increase in satisfying sexual activity in women with HSDD. However, there were no mention about other side effects.
May 25th, 2010 at 10:17 pm
Interesting! Personally I think it would be fantastic if this does get FDA approval as so many women do suffer from HSDD, it’s not just men who have sexual arousal problems.